article thumbnail

State Boards of Pharmacy Missing in Action During Opioid Crisis

Policy Prescription

state boards of pharmacy to properly regulate pharmacies that irresponsibly and too often illegally profited from opioid drug sales to patients. So, where was the West Virginia Board of Pharmacy? This post should serve as the beginning of a serious inquiry into the failure of U.S. It’s really straightforward.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog: Biosimilars

Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. This post examines the Zarzamora pharmacy and prescribing red flags decision. d/b/a CVS/Pharmacy, Nos.

Pharmacy 139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article FDA Thank You In unanimous decision, Supreme Court solves FDA’s ‘standing’ issue

Agency IQ

In unanimous decision, Supreme Court solves FDA’s ‘standing’ issue Two lower courts had articulated a Rube Goldberg-esque theory of “standing” – the right of a person or organization to sue another entity – based on the idea that doctors not prescribing mifepristone or treating patients who had taken it had experienced economic harms.

FDA 40
article thumbnail

How large language models can elevate clinical research

Drug Discovery World

billion 1 is the estimated cost of bringing a new drug from the drawing board to pharmacy shelves today. Moreover, the current landscape lacks comprehensive regulations specifically tailored to the use of AI in healthcare, leaving a gray area around the responsible deployment of LLMs. An oncology trial generates about 3.1

article thumbnail

Women in STEM with Dr Catherine Sheehan

Drug Target Review

The regulatory science project I pursued for my first master’s degree titled, “21st Century Pharmaceutical Excipients: Consequences of a Global Supply Chain and Lack of Excipient Regulations” aimed to draw attention to the risks created by the lack of sufficient oversight of the pharmaceutical excipient supply chain.

article thumbnail

Beyond blood tests: The evolution of digital biomarkers in clinical research

Drug Discovery World

Digital biomarkers promise to transform preventive medicine and clinical trials, but also raise issues of security, regulation and potential disparities in access. In certain cases, to pinpoint the specific type of ILD and its severity, doctors might recommend a lung biopsy.

article thumbnail

Who are the AACR Scientific Achievement Award winners?

Drug Discovery World

as a master regulator of prostate differentiation and cancer initiation and progression, for generating unique and reliable murine bladder and prostate cancer models, and for steadfast commitment to serving as a leader, mentor, and supporter of women in cancer research. Doctors said not to worry.